Walter
Stewart, PhD, MPH

Walter “Buzz” Stewart is a Health2047 Advisor and an internationally-renowned researcher. He has authored more than 400 scientific manuscripts, pioneered understanding of EHR data uses for real world evidence, and created successful academic research programs, start-ups, and healthcare R&D units. With more than 15 years of experience working in a variety of health systems, Buzz […]

Robert
Wah, MD

Dr. Robert Wah, an Advisor to Health2047, brings experience and expertise in healthcare, information technology, advocacy, and strategic development across public and private sectors. Robert previously served as president of the American Medical Association and Chair of the AMA board of trustees. For over 12 years, Robert served as Global Chief Medical Officer at CSC […]

Joe
Marks, PhD

Joe Marks is the co-founder of Caboodle Technologies. Previously, he co-founded Upfront Analytics in April 2012 to help revolutionize market research through playful engagement with respondents. From 2007 to 2012, Joe created and led Disney Research, the premier technology lab in the media & entertainment industry. Prior to that, he was the research director at […]

Georgia
Papathomas, PhD

Georgia Papathomas has over 40 years of experience in health, life sciences, telecommunications, and technology, and is an active investor, advisor and board member with a focus on the healthcare and technology sectors. Dr. Papathomas currently serves as an Advisor to Health2047, the Executive Board of ArisGlobal, and the Executive Advisory Board of nFerence. Dr. […]

Eric
Yablonka

Eric Yablonka, an Advisor to Health2047, brings over 35 years of industry-leading healthcare technology experience with a focus on advising and consulting companies, funds, and organizations on all matters relating to health information technologies, digital and business, and their applications. He previously served as the Chief Information Officer and Associate Dean at Stanford Health Care […]

Craig
Taylor

Craig Taylor is a Health2047 Advisor and the head of life science investments at Alloy Ventures. His career in venture capital began in 1977, and since co-founding Alloy Ventures in 1996, he and his partners have invested in over one hundred companies. Most recently, Craig has focused on investing in life science companies that span […]

Charles “Chuck”
Hoyng, PhD, JD

Charles is an Advisor at Health2047. Charles brings over 30 years of experience in negotiating and drafting life sciences technology license agreements, and counseling in the development, protection, manufacture and distribution of products, particularly in the areas of pharmaceutical products, medical diagnostic products, and medical devices. After earning his PhD in Organic Chemistry from MIT, […]